I en stor case- kontrol undersøgelse vurderedes vaccinen til at have en effekt på 85% mod alle former for skoldkopper og 97% mod moderat til svær sygdom.
In a large case-control study, the vaccine was estimated to be 85% effective against all forms of varicella and 97% effective against moderately severe and severe disease.